Compare BioNano Genomics Inc (BNGO) vs Old Dominion Freight Line Inc (ODFL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Old Dominion Freight Line Inc — how do they compare? BioNano Genomics Inc trades at $1.17 (market cap $13.66M), while Old Dominion Freight Line Inc trades at $212.27 (market cap $43.43B). The key difference: Old Dominion Freight Line Inc is far larger — about 3179.4× BioNano Genomics Inc's market cap, and Old Dominion Freight Line Inc pays a 0.55% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | ODFL | |
|---|---|---|
Market Cap | $13.66M | $43.43B |
Sector | Health | Industrials |
52-Week High | $4.92 | $248.73 |
52-Week Low | $1.06 | $126.29 |
Enterprise Value | $16.26M | $43.17B |
Dividend Yield | — | 0.55% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.16 with a bullish technical signal supported by moving averages. The company shows improving financial trends with narrowing losses and consistent earnings beats, though it remains unprofitable with negative margins. Recent news highlights operational progress including debt retirement and scientific publications. Valuation ratios appear attractive with P/S of 0.31 and P/B of 0.36.
The outlook remains speculative given persistent losses, but improving cash flow trends and analyst optimism provide catalysts. Key risks include ongoing negative profitability and competitive pressures in genomics. With 57% analyst buy ratings and bullish technical momentum, the stock offers high-risk growth potential for investors comfortable with biotech volatility.
ODFL trades at $212.55, down 1.76% today, with a bearish technical signal despite recent earnings beats. The company maintains strong profitability with 19.44% net margins and 24.82% ROE, though valuation metrics remain elevated with a P/E of 40.28. Recent Q2 2026 earnings of $1.68 per share exceeded expectations, driven by yield improvements and cost discipline amid ongoing freight market pressures.
The stock faces headwinds from premium valuation and mixed analyst sentiment (33% buy, 56% hold), but strong fundamentals and consistent earnings outperformance provide support. Key risks include freight volume recovery uncertainty and execution pressure given high expectations. The consensus price target of $239.85 suggests 13% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Old Dominion Freight Line Inc
Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →
